U
Unity Biotechnology
Unity develops senolytic medicines that selectively eliminate senescent cells—aging cells that accumulate and drive inflammation and tissue dysfunction—targeting age-related diseases.
Company Details
Stage
Public
Total Funding
$300M
Founded
2011
Headquarters
South San Francisco, CA, USA
Website
unitybiotechnology.comIs this your company?
Claim your profile to edit details, add a logo, and see analytics.
Claim ProfileAbout Unity Biotechnology
Unity develops senolytic medicines that selectively eliminate senescent cells—aging cells that accumulate and drive inflammation and tissue dysfunction—targeting age-related diseases.